The Role of Galectin-3/MAC-2 in the Activation of the Innate-Immune Function of Phagocytosis in Microglia in Injury and Disease
The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Microglia are a self-sustained population of immune/myeloid cells present throughout the central nervous system (CNS). Microglia are in a "resting" state in the normal adult CNS. They turn "active" in injury and disease (e.g., trauma, neurodegeneration, and infection). Activated microglia can be beneficial as well as detrimental/neurotoxic. The innate-immune function of phagocytosis of tissue debris, neurotoxic factor, and pathogens is a beneficial function of microglia. The current manuscript reviews the role of Galectin-3 (known also as MAC-2; Galectin-3/MAC-2) in the activation of the phagocytosis of degenerated myelin that is mediated by complement receptor-3 (known also as MAC-1; CD11b/CD18; alphaMbeta2 integrin) and SRA (scavenger receptor-AI/II). Observations suggest that Galectin-3/MAC-2 may act as a molecular switch that activates phagocytosis by up-regulating and prolonging KRas-GTP-dependent PI3K (phosphatidylinositol 3-kinase) activity. A similar mechanism may regulate the phagocytosis of other tissue debris, neurotoxic factors and pathogens in neurodegenerative and infectious diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TD2 genes were well characterized for regulation of phagocytosis and microglial activation (e.g. Lgasl3; Rotshenker, 2009), microglial survival (e.g. Spp1; Rabenstein et al., 2016), alternative M2 activation of microglia (Zhou et al., 2015), and lysosomal proton pump (Atp6v0d2).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Rotshenker, 2009
In the citing paper
“Lgals3 is a critical regulator of microglia activation (Rotshenker, 2009), and it facilitates phagocytosis (Sano et al., 2003).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Rotshenker, 2009
Citations
Cites
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“Neuroinflammation, in general, and activated microglia, in particular, can be beneficial if strictly controlled, but detrimental/neurotoxic if uncontrolled (Block et al. 2007; Gao and Hong 2008; Hanisch and Kettenmann 2007; Kreutzberg 1996; Rio-Hortega 1932; Skaper 2007).”
BackgroundMicroglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · cited 1×
“Neuroinflammation, in general, and activated microglia, in particular, can be beneficial if strictly controlled, but detrimental/neurotoxic if uncontrolled (Block et al. 2007; Gao and Hong 2008; Hanisch and Kettenmann 2007; Kreutzberg 1996; Rio-Hortega 1932; Skaper 2007).”
BackgroundMicroglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676 · cited 1×
“Neuroinflammation, in general, and activated microglia, in particular, can be beneficial if strictly controlled, but detrimental/neurotoxic if uncontrolled (Block et al. 2007; Gao and Hong 2008; Hanisch and Kettenmann 2007; Kreutzberg 1996; Rio-Hortega 1932; Skaper 2007).”
BackgroundLocal self-renewal can sustain CNS microglia maintenance and function throughout adult life
Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W., & Rossi, F. M. V. (2007) · Nature Neuroscience · doi:10.1038/nn2014 · Cited by 1,643
Glial inhibition of CNS axon regeneration
Yiu, G., & He, Z. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1956 · Cited by 1,495
Galectin-3: An open-ended story
Dumic, J., Dabelic, S., & Flögel, M. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.12.020 · Cited by 1,169
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions
Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.-K., Mack, M., Heikenwalder, M., Brück, W., Priller, J., & Prinz, M. (2007) · Nature Neuroscience · doi:10.1038/nn2015 · Cited by 1,089 · cited 1×
“The removal of degenerated myelin is critical also for repair and for minimizing damage to axons and myelin in MS/EAE, since degenerated myelin inhibits remyelination by oligodendrocytes (Kotter et al. 2006) and further activates the complement system to form membrane attack complexes which add to the destruction of i…”
BackgroundCytology & cellular pathology of the nervous system
Penfield, W. G. (1965) · Medical Entomology and Zoology · Cited by 1,035
Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain
Alliot, F., Godin, I., & Pessac, B. (1999) · Developmental Brain Research · doi:10.1016/s0165-3806(99)00113-3 · Cited by 884 · cited 1×
“Recruitment of additional microglia precursor cells from the circulation in adulthood occurs only under specific conditions (Ajami et al. 2007; Alliot et al. 1999; Mildner et al. 2007).”
BackgroundGalectins: structure, function and therapeutic potential
Yang, R.-Y., Rabinovich, G. A., & Liu, F.-T. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000719 · Cited by 862
Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
Gao, H.-M., & Hong, J.-S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.05.002 · Cited by 821
Myelin Impairs CNS Remyelination by Inhibiting Oligodendrocyte Precursor Cell Differentiation
Kotter, M. R., Li, W.-W., Zhao, C., & Franklin, R. J. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2615-05.2006 · Cited by 768
Perry, V. H., Brown, M. C., & Gordon, S. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.4.1218 · Cited by 604
Ho, M. K., & Springer, T. A. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.128.3.1221 · Cited by 426
Stoll, G., Jander, S., & Myers, R. R. (2002) · Journal of the Peripheral Nervous System · doi:10.1046/j.1529-8027.2002.02002.x · Cited by 383
Reichert, F., Saada, A., & Rotshenker, S. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-03231.1994 · Cited by 230
Mead, R. J., Singhrao, S. K., Neal, J. W., Lassmann, H., & Morgan, B. P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.458 · Cited by 198
Cytology and Cellular Pathology of the Nervous System.
(1932) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1932.02240030272017 · Cited by 197
The Brain as a Target for Inflammatory Processes and Neuroprotective Strategies
SKAPER, S. D. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1403.002 · Cited by 192
Griffin, J. W., George, R., Lobato, C., Tyor, W. R., Li, C. Y., & Glass, J. D. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90129-9 · Cited by 170
Rotshenker, S. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:21:1:65 · Cited by 143
Bell, M. D., Lopez-Gonzalez, R., Lawson, L. J., Hughes, D. A., Fraser, I. P., Gordon, S., & Perry, V. H. (1994) · Journal of Neurocytology · doi:10.1007/bf01191555 · Cited by 124
Reichert, F., & Rotshenker, S. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(02)00008-6 · Cited by 119
Saada, A., Reichert, F., & Rotshenker, S. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.1.159 · Cited by 115
Phagocytic properties of microglia in vitro: Implications for a role in multiple sclerosis and EAE
Smith, M. E. (2001) · Microscopy Research and Technique · doi:10.1002/jemt.1123 · Cited by 107
The cytokine network of Wallerian degeneration: IL-10 and GM-CSF
Be′eri, H., Reichert, F., Saada, A., & Rotshenker, S. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.t01-1-00277.x · Cited by 107
Rinner, W. A., Bauer, J., Schmidts, M., Lassmann, H., & Hickey, W. F. (1995) · Glia · doi:10.1002/glia.440140403 · Cited by 99
Galectin-3/MAC-2 in Experimental Allergic Encephalomyelitis
Reichert, F., & Rotshenker, S. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7229 · Cited by 97
Deficient activation of microglia during optic nerve degeneration
Reichert, F., & Rotshenker, S. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00112-9 · Cited by 91
Rotshenker, S., Reichert, F., Gitik, M., Haklai, R., Elad‐Sfadia, G., & Kloog, Y. (2008) · Glia · doi:10.1002/glia.20713 · Cited by 85
Spatiotemporal Organization of Ras Signaling: Rasosomes and the Galectin Switch
Ashery, U., Yizhar, O., Rotblat, B., Elad‐Sfadia, G., Barkan, B., Haklai, R., & Kloog, Y. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9059-3 · Cited by 77
Slobodov, U., Reichert, F., Mirski, R., & Rotshenker, S. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7559 · Cited by 45
Silverman, B. A., Carney, D. F., Johnston, C. A., Vanguri, P., & Shin, M. L. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb12706.x · Cited by 45
Makranz, C., Cohen, G., Baron, A., Levidor, L., Kodama, T., Reichert, F., & Rotshenker, S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.11.007 · Cited by 41
Modulation (Inhibition and Augmentation) of Complement Receptor-3-Mediated Myelin Phagocytosis
Reichert, F., Slobodov, U., Makranz, C., & Rotshenker, S. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0383 · Cited by 40
Easing the brakes on spinal cord repair
McKerracher, L. J., & David, S. (2004) · Nature Medicine · doi:10.1038/nm1004-1052 · Cited by 38
Cohen, G., Makranz, C., Spira, M., Kodama, T., Reichert, F., & Rotshenker, S. (2006) · Glia · doi:10.1002/glia.20304 · Cited by 32
Therapeutic Approaches to Promoting Axonal Regeneration in the Adult Mammalian Spinal Cord
Hannila, S. S., Siddiq, M. M., & Filbin, M. T. (2006) · International review of neurobiology · doi:10.1016/s0074-7742(06)77003-9 · Cited by 23
Cited by
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
Transcellular degradation of axonal mitochondria
Davis, C.-H. O., Kim, K.-Y., Bushong, E. A., Mills, E. A., Boassa, D., Shih, T., Kinebuchi, M., Phan, S., Zhou, Y., Bihlmeyer, N. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404651111 · Cited by 673
Phagocytosis of Microglia in the Central Nervous System Diseases
Fu, R., Shen, Q., Xu, P., Luo, J. J., & Tang, Y. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8620-6 · Cited by 652
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis
Sierra, A., Abiega, O., Shahraz, A., & Neumann, H. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00006 · Cited by 574
“In fact, antigen presentation in the CNS is thought to occur not in the parenchyma, but in the meninges and choroid plexus, which contain perivascular APCs, or by direct drainage of CNS antigens in the cerebrospinal fluid from the subarachnoidal space to channels in the cribiform plate and…”
BackgroundWallerian degeneration: the innate-immune response to traumatic nerve injury
Rotshenker, S. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-109 · Cited by 510
“GTP/PI3K-dependent phagocytosis of degenerated myelin is similarly activated by Galectin-3/MAC-2 [143,144].”
Background
Metadata
- Authors
- Rotshenker, S.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Corresponding author
- Rotshenker, Shlomo
- ORCID
- Rotshenker, Shlomo
- Venue
- Journal of Molecular Neuroscience
- Published
- 2009-02-28
- Volume
- 39
- Issue
- 1-2
- Pages
- 99-103
- ISSN
- 0895-8696 (ISSN-L)
- 1559-1166
- OpenAlex
- W2086321695
- Cited by
- 111
- References
- 39
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 8 · 2021: 7 · 2020: 7 · 2019: 7 · 2018: 6 · 2017: 10 · 2016: 5 · 2015: 8 · 2014: 8 · 2013: 7 · 2012: 8
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Molecular Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Israel Science Foundation
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Galectins and Cancer Biology
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- galectin-3, microglia, phagocytosis, innate immunity, microglial activation, complement receptor 3, CD11b/CD18, scavenger receptor A, myelin phagocytosis, PI3K signaling, neurodegeneration, neuroinflammation, central nervous system injury
- MeSH terms
- Encephalomyelitis, Autoimmune, Experimental, Immunity, Innate, Myelin Sheath, Nerve Degeneration, Nervous System Diseases, Phagocytosis, Signal Transduction, Microglia, Galectin 3, CD11b Antigen, Scavenger Receptors, Class A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.